SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[Skystar Bio-Pharmaceutical Announces Second Quarter 2009 Results XI'AN, CHINA – August 14, 2009 – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) SECOND QUARTER 2009 & RECENT HIGHLIGHTS § Revenues increased 39.4% year-over-year to $6.2 million § Gross margin improved to 52.6% from 51.6% in the second quarter of 2008 § Income from operations increased by 37.6% year-over-year to $1.7 million § Began]